We are StimLabs, a company born in 2015 from a profound desire to advance the state of regenerative medicine. Our journey began with a clear mission: to assemble exceptional scientific and clinical minds to develop and commercialize new bioactive technologies that can truly make a difference in patients' lives. We're proud that within just a year of our inception, we had already conceptualized and launched a suite of innovative amniotic-derived products, built an extensive product pipeline targeting a wide range of clinical applications, and established a robust portfolio of intellectual property. Our commitment is to offer every individual the opportunity for a better quality of life.
At StimLabs, we're driven by the philosophy of pushing progress in regenerative medicine. We strive to ensure that patients receive the most advanced and effective treatments available, while also recognizing and addressing the diverse needs of healthcare providers, various care sites, and payors. Our team, comprised of industry leaders, is passionately dedicated to providing the best possible care through continuous innovation and the development of personalized solutions. We focus on scientifically grounded techniques to optimally retain the important native components and structures of placental tissues. This dedication led to the creation of the first placental membrane allograft that successfully retained all three layers of the native tissue: the amnion, intermediate layer, and chorion. We are pioneers, always looking for ways to enhance patients' quality of life through meaningful innovation, a principle that has guided us since our very first days. Our vision is to be the world's most trusted and effective regenerative medicine company, and every day, we work towards restoring the body's inherent form and function.
Our portfolio includes a comprehensive range of products designed to address various clinical needs, such as our patented Clearify® technology, which allows for the retention of all three layers of placental tissue while effectively cleaning it. We've introduced groundbreaking products like Revita®, the first full-thickness placental membrane allograft in a shelf-stable format, and Ascent, an amniotic fluid allograft. We are constantly expanding our offerings, like Enverse™, a translucent dehydrated complete human placental membrane allograft, to meet the evolving needs of healthcare facilities and simplify patient care for physicians and hospital systems. We are committed to delivering superior products and being a trusted partner to both physicians and patients. Our growth is a testament to our team's dedication; from under 40 employees in early 2020, we grew to over 100 by the year's end, significantly expanding our reach and impact. We believe in our people and foster a culture where everyone has a voice and can grow both personally and professionally.
United States
Germany only
